Study Title: RANDOMIZED PHASE II STEREOTACTIC ABLATIVE RADIATION THERAPY (SABR) FOR METASTATIC UNRESECTED RENAL CELL CARCINOMA (RCC) RECEIVING IMMUNOTHERAPY (SAMURAI)
For more information about the trial above please contact the study team:Self Regional Medical CenterAffiliate Principal Investigator, Wood, Clint, at clint.wood@selfregional.org.Study Coordinator, Blalock, Margaret, at margaret.bentley@selfregional.org.Study Coordinator, Nelson, Kristina, at knelson@selfregional.org.Trial opened at the following institutions: Self Regional Medical Center